BRIEF published on 12/11/2024 at 12:16, 1 year 3 months ago Threshold crossing by the CDC in ABIONYX PHARMA Voting Rights CDC Threshold Crossing ABIONYX Pharma Bpifrance Participations
BRIEF published on 12/11/2024 at 12:13, 1 year 3 months ago Franchissement de seuil par Bpifrance dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX
BRIEF published on 12/11/2024 at 12:13, 1 year 3 months ago Threshold crossing by Bpifrance in ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX
PRESS RELEASE published on 12/11/2024 at 12:11, 1 year 3 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% des droits de vote de ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Franchissement De Seuil Caisse Des Dépôts Et Consignations ABIONYX Pharma Bpifrance Participations 5% Droits De Vote
PRESS RELEASE published on 12/11/2024 at 12:08, 1 year 3 months ago Franchissement de seuil Bpifrance declared indirectly holding 4.67% of Abionyx Pharma's capital and 7.34% of voting rights as of December 5, 2024 Déclaration Franchissement De Seuil AMF Bpifrance ABIONYX Pharma
BRIEF published on 12/10/2024 at 10:51, 1 year 3 months ago Franchissement de seuil par Cyrille Tupin chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions ABIONYX Pharma Cyrille Tupin
BRIEF published on 12/10/2024 at 10:51, 1 year 3 months ago Threshold crossing by Cyrille Tupin at ABIONYX PHARMA Voting Rights Actions Threshold Crossing ABIONYX Pharma Cyrille Tupin
PRESS RELEASE published on 12/10/2024 at 10:46, 1 year 3 months ago Franchissement de seuil Déclaration de franchissement de seuil par M. Cyrille Tupin concernant ABIONYX PHARMA. Détention de 4,56% du capital et 6,06% des droits de vote Déclaration Droits De Vote Franchissement De Seuil ABIONYX Pharma Cyrille Tupin
BRIEF published on 11/14/2024 at 19:05, 1 year 4 months ago ABIONYX Pharma : Bilan financier du troisième trimestre 2024 Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma T3 2024
BRIEF published on 11/14/2024 at 19:05, 1 year 4 months ago ABIONYX Pharma: Third quarter 2024 financial report Biotechnology Treasury Turnover Q3 2024 ABIONYX Pharma
Published on 03/24/2026 at 12:35, 41 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 43 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 46 minutes ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 12:30, 46 minutes ago Sidney Resources Corporation Identifies District-Scale Structural and Hydrothermal System at Warren Project; Survey Confirms Strategic Claim Position Within Core Target Corridor
Published on 03/24/2026 at 12:30, 46 minutes ago Avidian Gold Announces Non-Brokered Private Placement for Gross Proceeds of up to $750,000
Published on 03/24/2026 at 13:05, 11 minutes ago Fortegra Selects Duck Creek Reinsurance and Clarity to Support Strategic Growth
Published on 03/24/2026 at 13:05, 11 minutes ago Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
Published on 03/24/2026 at 12:53, 23 minutes ago Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen
Published on 03/24/2026 at 12:37, 38 minutes ago CENIT concludes fiscal year 2025 with a strong operational Q4 and looks confidently toward the current year (EBITDA Forecast 2026 +46.6%)
Published on 03/24/2026 at 10:58, 2 hours 18 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 2 hours 18 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 5 hours 31 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 5 hours 31 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 5 hours 46 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
